Amgen to invest $200m in new Singapore manufacturing facility
Company intends to begin the construction of the new facility shortly to expand the monoclonal antibody manufacturing capacity. Amgen operations executive vice president Madhu Balachandran said the planning
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.